Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Bioorg Med Chem Lett ; 22(17): 5475-9, 2012 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-22850209

RESUMEN

The aim of the present study was to verify the important role of Maillard reaction in the protective effect of heat-processed ginsenoside Re-serine mixture against oxidative stress-induced nephrotoxicity. The free radical-scavenging activity of ginsenoside Re-serine mixture was increased by heat-processing. Ginsenoside Re was transformed into less-polar ginsenosides such as Rg(2), Rg(6) and F(4) by heat-processing, and the glucose molecule at carbon-20 was separated. The improved-free radical-scavenging activity by heat-processing was mediated by the generation of antioxidant Maillard reaction products (MRPs) from the reaction of glucose with serine. Moreover, MRPs from ginsenoside Re-serine mixture showed protective effect against cisplatin-induced renal epithelial cell damage.


Asunto(s)
Antineoplásicos/toxicidad , Antioxidantes/farmacología , Cisplatino/toxicidad , Citoprotección/efectos de los fármacos , Ginsenósidos/farmacología , Serina/farmacología , Animales , Antioxidantes/química , Línea Celular , Supervivencia Celular/efectos de los fármacos , Citotoxinas/toxicidad , Ginsenósidos/química , Calor , Riñón/citología , Riñón/efectos de los fármacos , Células LLC-PK1 , Reacción de Maillard/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Panax/química , Serina/química , Porcinos
2.
Bioorg Med Chem Lett ; 22(12): 4122-6, 2012 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-22579420

RESUMEN

Amorphastilbol (APH-1), isolated from a Robinia pseudoacacia var. umbraculifer [corrected] seed extract, is a biologically interesting natural trans-stilbene compound with dual peroxisome proliferator-activated receptor (PPAR) α/γ agonist activity. After total synthesis of APH-1 and its derivatives by Pd-catalyzed Suzuki-Miyaura cross-coupling of a common (E)-styryl bromide intermediate and various aromatic trifluoroborate compounds, we biologically evaluated APH-2-APH-12 for PPAR agonist activity. APH-4 and APH-11 were effective PPARα/γ transcriptional activators, compared with APH-1. Therefore, we suggest that APH-4 and APH-11 are novel dual PPARα/γ agonists and are potentially useful for treating type 2 diabetes by enhancing glucose and lipid metabolism.


Asunto(s)
Cannabinoides/síntesis química , Hipoglucemiantes/síntesis química , PPAR alfa/agonistas , PPAR gamma/agonistas , Robinia/química , Estilbenos/síntesis química , Adipocitos/citología , Adipocitos/efectos de los fármacos , Animales , Boratos/química , Cannabinoides/aislamiento & purificación , Cannabinoides/farmacología , Diferenciación Celular/efectos de los fármacos , Línea Celular , Humanos , Hipoglucemiantes/aislamiento & purificación , Hipoglucemiantes/farmacología , Metabolismo de los Lípidos/efectos de los fármacos , Ratones , PPAR alfa/metabolismo , PPAR gamma/metabolismo , Extractos Vegetales/química , Semillas/química , Estilbenos/aislamiento & purificación , Estilbenos/farmacología
3.
Mar Drugs ; 10(10): 2222-2233, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23170079

RESUMEN

An extract of the red alga, Neorhodomela aculeata, exhibited antiviral activity against human rhinoviruses. Bioassay-guided purification was performed to yield six compounds, which were subsequently identified as lanosol (1) and five polybromocatechols (2-6) by spectroscopic methods, including 1D and 2D NMR and mass spectrometric analyses. Structurally, all of these compounds, except compound 5, contain one or two 2,3-dibromo-4,5-dihydroxyphenyl moieties. In a biological activity assay, compound 1 was found to possess antiviral activity with a 50% inhibitory concentration (IC50) of 2.50 µg/mL against HRV2. Compound 3 showed anti-HRV2 activity, with an IC50 of 7.11 µg/mL, and anti-HRV3 activity, with an IC50 of 4.69 µg/mL, without demonstrable cytotoxicity at a concentration of 20 µg/mL. Collectively, the results suggest that compounds 1 and 3 are candidates for novel therapeutics against two different groups of human rhinovirus.


Asunto(s)
Antivirales/farmacología , Catecoles/química , Catecoles/farmacología , Rhinovirus/efectos de los fármacos , Rhodophyta/química , Rhodophyta/metabolismo , Antivirales/química , Catecoles/metabolismo , Células HeLa , Humanos , Estructura Molecular
4.
Bioorg Med Chem Lett ; 18(14): 4047-50, 2008 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-18565749

RESUMEN

Three new polyketides, cyathuscavins A (1), B (2), and C (3) were isolated from the mycelium culture of Cyathus stercoreus. The structures of the compounds were elucidated on the basis of NMR and mass spectroscopic data. Antioxidant activities of the compounds were evaluated by the scavenging ability against ABTS(+), DPPH, and superoxide anion radicals. Cyathuscavins A-C showed significant antioxidant activity comparable to those of reference antioxidants, BHA and Trolox. Cyathuscavins A-C protected supercoiled plasmid DNA from Fe(2+)/H(2)O(2)-induced breakage.


Asunto(s)
Basidiomycota/metabolismo , Química Farmacéutica/métodos , ADN/química , Depuradores de Radicales Libres/farmacología , Macrólidos/farmacología , Antioxidantes/química , Antioxidantes/metabolismo , Compuestos de Bifenilo/química , Cromanos/química , Diseño de Fármacos , Hidrazinas/química , Peróxido de Hidrógeno/química , Macrólidos/aislamiento & purificación , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Modelos Químicos , Picratos , Superóxidos/química
5.
J Microbiol Biotechnol ; 18(4): 676-81, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18467860

RESUMEN

To obtain a natural antioxidant from a marine biomass, this study investigated the antioxidative activity of methanolic extracts from the marine brown alga, Ishige okamurae collected off Jeju Island. A potent free radical scavenging activity was detected in the ethyl acetate fraction containing polyphenolic compounds, and the potent antioxidant elucidated as a kind of phlorotannin, diphlorethohydroxycarmalol, by NMR and mass spectroscopic data. The free radical scavenging activities of the diphlorethohydroxycarmalol were investigated in relation to 1,1-diphenyl-2-picrylhydrazyl (DPPH), alkyl, and hydroxyl radicals using an electron spin resonance (ESR) system. The diphlorethohydroxycarmalol was found to scavenge DPPH (IC50=3.41 microM) and alkyl (IC50=4.92 microM) radicals more effectively than the commercial antioxidant, ascorbic acid. Therefore, these results present diphlorethohydroxycarmalol as a new phlorotannin with a potent antioxidative activity that could be useful in cosmetics, foods, and pharmaceuticals.


Asunto(s)
Depuradores de Radicales Libres/química , Depuradores de Radicales Libres/farmacología , Compuestos Heterocíclicos con 3 Anillos/química , Compuestos Heterocíclicos con 3 Anillos/farmacología , Phaeophyceae/metabolismo , Compuestos de Bifenilo , Espectroscopía de Resonancia por Spin del Electrón , Depuradores de Radicales Libres/aislamiento & purificación , Compuestos Heterocíclicos con 3 Anillos/aislamiento & purificación , Phaeophyceae/química , Picratos/análisis , Agua de Mar
6.
J Ginseng Res ; 38(1): 22-7, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24558306

RESUMEN

BACKGROUND: Research has been conducted with regard to the development of methods for improving the pharmaceutical effect of ginseng by conversion of ginsenosides, which are the major active components of ginseng, via high temperature or high-pressure processing. METHODS: The present study sought to investigate the anticancer effect of heat-processed American ginseng (HAG) in human gastric cancer AGS cells with a focus on assessing the role of apoptosis as an important mechanistic element in its anticancer actions. RESULTS AND CONCLUSION: HAG significantly reduced the cancer cell proliferation, and the contents of ginsenosides Rb1 and Re were markedly decreased, whereas the peaks of less-polar ginsenosides [20(S,R)-Rg3, Rk1, and Rg5] were newly detected. Based on the activity-guided fractionation of HAG, ginsenoside 20(S)-Rg3 played a key role in inducing apoptosis in human gastric cancer AGS cells, and it was generated mainly from ginsenoside Rb1. Ginsenoside 20(S)-Rg3 induced apoptosis through activation of caspase-3, caspase-8, and caspase-9, as well as regulation of Bcl-2 and Bax expression. Taken together, these findings suggest that heat-processing serves as an increase in the antitumor activity of American ginseng in AGS cells, and ginsenoside 20(S)-Rg3, the active component produced by heat-processing, induces the activation of caspase-3, caspase-8, and caspase-9, which contributes to the apoptotic cell death.

7.
Food Chem ; 138(2-3): 876-83, 2013 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-23411191

RESUMEN

Ginsenosides are the main active components of Panax ginseng. Structural changes in diol type ginsenosides along with generation of Maillard reaction products (MRPs) are strongly associated with increased free radical-scavenging activities. Ginsenoside Re, one of the major triol type ginsenosides of P. ginseng, possesses a hydrophobic four-ring steroid-like structure with hydrophilic sugar moieties at carbons-3 and -20. The aim of the present study was to identify changes in the structure, antioxidant and anticancer effects of ginsenoside Re upon Maillard reaction. Ginsenoside Re was transformed into less-polar ginsenosides, namely Rg(2), Rg(6) and F(4) by heat-processing. Free radical-scavenging activity of the ginsenoside Re-lysine mixture increased upon heat processing. This improved free radical-scavenging activity mediated by antioxidant MRPs, which were generated through Maillard reaction of a glucosyl moiety separated from carbon-20 of ginsenoside Re and lysine. The increased anticancer effect of ginsenoside Re-lysine mixture upon heat processing was mainly derived from the generation of less-polar ginsenosides through the regulation of Bcl-2 and Bax, as well as caspase-dependent apoptotic pathway. These results reported here have shed significant new lights on the mechanism of increased antioxidant and anticancer effects of P. ginseng upon heat processing.


Asunto(s)
Antineoplásicos Fitogénicos/química , Antioxidantes/química , Ginsenósidos/química , Lisina/química , Panax/química , Antineoplásicos Fitogénicos/farmacología , Antioxidantes/farmacología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Ginsenósidos/farmacología , Humanos , Lisina/farmacología , Reacción de Maillard , Estructura Molecular
8.
Food Chem ; 135(4): 2430-5, 2012 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-22980824

RESUMEN

Ginsenoside Re, one of the major triol type ginsenosides contained in Panax ginseng, has a hydrophobic four-ring steroid-like structure with hydrophilic sugar moieties at carbon-3 and -20. The aim of the present study was to identify the changes in structure and antioxidant activity of ginsenoside Re by the Maillard reaction, which has not been reported yet. The free radical-scavenging activity of ginsenoside Re-alanine mixture was increased by heat-processing. Ginsenoside Re was gradually changed into Rg(2), Rg(6) and F(4) by heat-processing, and the glucosyl moiety at carbon-20 was separated. The improved-free radical-scavenging activity by heat-processing was mediated by the generation of antioxidant Maillard reaction products (MRPs). Antioxidant MRPs were generated from the reaction of glucose and alanine. Based on the viability results of LLC-PK1 renal epithelial cells, MRPs and less-polar ginsenosides contributed to the combined renoprotective effect against oxidative renal damage. Maillard reaction is importantly involved in the increased antioxidant effect of ginsenoside by heat-processing.


Asunto(s)
Alanina/química , Antioxidantes/química , Ginsenósidos/química , Panax/química , Extractos Vegetales/química , Alanina/farmacología , Animales , Antioxidantes/farmacología , Línea Celular , Ginsenósidos/farmacología , Calor , Riñón/metabolismo , Células LLC-PK1 , Reacción de Maillard , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Porcinos
9.
Exp Mol Med ; 43(10): 580-6, 2011 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-21822049

RESUMEN

Malignant glioma is the most frequent type in brain tumors. The prognosis of this tumor has not been significantly improved for the past decades and the average survival of patients is less than one year. Thus, an effective novel therapy is urgently needed. TNF-related apoptosis inducing ligand (TRAIL), known to have tumor cell-specific killing activity, has been investigated as a novel therapeutic for cancers. We have developed Ad-stTRAIL, an adenovirus delivering secretable trimeric TRAIL for gene therapy and demonstrated the potential to treat malignant gliomas. Currently, this Ad-stTRAIL gene therapy is under phase I clinical trial for malignant gliomas. Here, we report preclinical studies for Ad-stTRAIL carried out using rats. We delivered Ad-stTRAIL intracranially and determined its pharmacokinetics and biodistribution. Most Ad-stTRAIL remained in the delivered site and the relatively low number of viral genomes was detected in the opposite site of brain and cerebrospinal fluid. Similarly, only small portion of the viral particles injected was found in the blood plasma and major organs and tissues, probably due to the brain-blood barrier. Multiple administrations did not lead to accumulation of Ad-stTRAIL at the injection site and organs. Repeated delivery of Ad-stTRAIL did not show any serious side effects. Our data indicate that intracranially delivered Ad-stTRAIL is a safe approach, demonstrating the potential as a novel therapy for treating gliomas.


Asunto(s)
Neoplasias Encefálicas/terapia , Encéfalo/metabolismo , Terapia Genética , Glioma/terapia , Ligando Inductor de Apoptosis Relacionado con TNF/farmacocinética , Adenoviridae/genética , Animales , Barrera Hematoencefálica , Encéfalo/efectos de los fármacos , Encéfalo/patología , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/patología , Ensayos Clínicos Fase I como Asunto , ADN Viral/metabolismo , Modelos Animales de Enfermedad , Sistemas de Liberación de Medicamentos , Evaluación Preclínica de Medicamentos , Glioma/genética , Glioma/metabolismo , Glioma/patología , Humanos , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Multimerización de Proteína/genética , Ratas , Bazo/efectos de los fármacos , Bazo/metabolismo , Bazo/patología , Ligando Inductor de Apoptosis Relacionado con TNF/genética
10.
PLoS One ; 4(2): e4545, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19229339

RESUMEN

Malignant gliomas are the most common primary brain tumors. Despite intensive clinical investigation and many novel therapeutic approaches, average survival for the patients with malignant gliomas is only about 1 year. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has shown potent and cancer-selective killing activity and drawn considerable attention as a promising therapy for cancers, but concerns over delivery and toxicity have limited progress. We have developed a secretable trimeric TRAIL (stTRAIL) and here evaluated the therapeutic potential of this stTRAIL-based gene therapy in brain tumors. An adenovirus (Ad-stTRAIL) delivering stTRAIL was injected into intra-cranial human glioma tumors established in nude mice and tumor growth monitored using the magnetic resonance imaging (MRI). Ad-stTRAIL gene therapy showed potent tumor suppressor activity with no toxic side effects at therapeutically effective doses. When compared with 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU), a conventional therapy for malignant gliomas, Ad-stTRAIL suppressed tumor growth more potently. The combination of Ad-stTRAIL and BCNU significantly increased survival compared to the control mice or mice receiving Ad-stTRAIL alone. Our data indicate that Ad-stTRAIL, either alone or combined with BCNU, has promise as a novel therapy for malignant gliomas.


Asunto(s)
Terapia Genética/métodos , Glioma/tratamiento farmacológico , Ligando Inductor de Apoptosis Relacionado con TNF/administración & dosificación , Adenoviridae/genética , Animales , Carmustina/uso terapéutico , Quimioterapia Combinada , Vectores Genéticos , Humanos , Imagen por Resonancia Magnética , Ratones , Trasplante de Neoplasias , Tasa de Supervivencia , Resultado del Tratamiento , Carga Tumoral
11.
Biotechnol Bioeng ; 98(3): 611-5, 2007 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-17421043

RESUMEN

Protein disulfide isomerase (PDI), one of the ER-resident molecular chaperones, forms and isomerizes disulfide bonds. This study attempts to investigate the effect of PDI expression level on specific productivity (q) of recombinant Chinese hamster ovary (rCHO) cells producing thrombopoietin (TPO) and antibody (Ab). To regulate the PDI expression level, the Tet-Off system was introduced in TPO and Ab producing CHO cells, and stable Tet-Off cells (TPO-Tet-Off and Ab-Tet-Off) were screened using the luciferase assay. The doxycycline-regulated PDI expression system in Tet-Off rCHO cells (Tet-TPO-PDI and Tet-Ab-PDI) was established by the cotransfection of pTRE-PDI and pTK-Hyg expression vector into TPO-Tet-Off and Ab-Tet-Off cells, respectively. Subsequent screening was done by Western blot analysis of PDI and an enzyme-linked immunosorbent assay of the secreted TPO and antibody. We cultured two Tet-TPO-PDI and two Tet-Ab-PDI clones, and all these clones showed an average of 2.5-fold increase in PDI expression when compared to the basal level. In both these cell lines the PDI expression was tightly controlled by various concentrations of doxycycline. The q of TPO (q(TPO)) was unaffected but that of antibody producing cells was increased by 15-27% due to the PDI expression level.


Asunto(s)
Anticuerpos Monoclonales/metabolismo , Doxiciclina/administración & dosificación , Proteína Disulfuro Isomerasas/metabolismo , Ingeniería de Proteínas/métodos , Trombopoyetina/metabolismo , Animales , Anticuerpos Monoclonales/genética , Células CHO , Cricetinae , Cricetulus , Relación Dosis-Respuesta a Droga , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/fisiología , Proteína Disulfuro Isomerasas/genética , Proteínas Recombinantes/biosíntesis , Trombopoyetina/genética
12.
Metab Eng ; 9(5-6): 452-64, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17892962

RESUMEN

Previously, the expression of caspase-3 siRNA could not effectively inhibit sodium butyrate (NaBu)-induced apoptotic cell death of recombinant Chinese hamster ovary (rCHO) cells producing human thrombopoietin (hTPO). Caspase-3 siRNA expressing cells appeared to compensate for the lack of caspase-3 by increasing active caspase-7 levels. For the successful inhibition of NaBu-induced apoptosis of rCHO cells, both caspase-3 and caspase-7 were down-regulated using the siRNA expression vector system. Co-down-regulation of caspase-3 and caspase-7 increased cell viability and extended culture longevity in serum-free culture in the presence or absence of 1mM NaBu addition. In the cultures with 1mM NaBu addition, the maximum hTPO concentration in rCHO cells with down-regulation of both caspases was approximately 55% higher than that in rCHO cells without down-regulation of caspases and approximately 16% higher than rCHO cells with down-regulation of only caspase-3. However, in the culture with 3mM NaBu, this strategy could not dramatically enhance the culture longevity and hTPO production, compared to Bcl-2 overexpression. The different result in hTPO production between down-regulation of caspases and Bcl-2 overexpression may be because the down-regulation of caspase-3 and caspase-7, unlike Bcl-2 overexpression, could not maintain mitochondrial membrane potential in the presence of 3mM NaBu. Taken together, co-down-regulation of caspase-3 and caspase-7 is effective in regard to extension of culture longevity and enhancement of hTPO production in a serum-free culture in the presence or absence of 1mM NaBu addition.


Asunto(s)
Apoptosis/efectos de los fármacos , Ácido Butírico/farmacología , Caspasa 3/metabolismo , Caspasa 7/metabolismo , Trombopoyetina/biosíntesis , Animales , Bencimidazoles/metabolismo , Células CHO , Carbocianinas/metabolismo , Supervivencia Celular/efectos de los fármacos , Cricetinae , Cricetulus , Medio de Cultivo Libre de Suero , Relación Dosis-Respuesta a Droga , Regulación hacia Abajo/efectos de los fármacos , Colorantes Fluorescentes/metabolismo , Potenciales de la Membrana/fisiología , Mitocondrias/fisiología , Proteínas Proto-Oncogénicas c-bcl-2/biosíntesis , ARN Interferente Pequeño/genética , Proteínas Recombinantes/biosíntesis , Trombopoyetina/genética , Transfección
13.
J Nat Prod ; 70(6): 1043-5, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17511503

RESUMEN

Three new polyketide-type antioxidative compounds, cyathusals A (1), B (2), and C (3), and the known pulvinatal (4) were obtained from the fermented mushroom Cyathus stercoreus. The structures of the compounds were characterized on the basis of NMR and mass spectroscopic data. Cyathusals A, B, and C and pulvinatal showed free radical scavenging activities on the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical with EC50 values of 41.6, 46.0, 26.6, and 28.6 microM, respectively, and on the 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonate) (ABTS) cation radical with EC50 values of 7.9, 11.1, 9.1, and 8.4 microM, respectively.


Asunto(s)
Agaricales/química , Antioxidantes/aislamiento & purificación , Antioxidantes/farmacología , Depuradores de Radicales Libres/aislamiento & purificación , Depuradores de Radicales Libres/farmacología , Compuestos Heterocíclicos con 3 Anillos/aislamiento & purificación , Compuestos Heterocíclicos con 3 Anillos/farmacología , Antioxidantes/química , Compuestos de Bifenilo , Fermentación , Depuradores de Radicales Libres/química , Compuestos Heterocíclicos con 3 Anillos/química , Corea (Geográfico) , Resonancia Magnética Nuclear Biomolecular , Picratos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA